CS01 | Elucidating the evil relationship of metabolic dysfunction–associated fatty liver disease with cardiovascular comorbidities: the complex interplay among hypercoagulability, inflammation and liver fibrosis

Background and aims: Metabolic dysfunction–associated fatty liver disease (MAFLD) represents an increasingly significant public health issue. The clinical course of MAFLD can be severe, with increased risk not only of liver-related morbidity and mortality, but also of cardiovascular (CV) diseases,...

Full description

Saved in:
Bibliographic Details
Format: Article
Language:English
Published: PAGEPress Publications 2025-08-01
Series:Bleeding, Thrombosis and Vascular Biology
Subjects:
Online Access:https://www.btvb.org/btvb/article/view/196
Tags: Add Tag
No Tags, Be the first to tag this record!